InvestorsHub Logo
Followers 30
Posts 5054
Boards Moderated 0
Alias Born 01/07/2020

Re: ilovetech post# 270849

Saturday, 05/02/2020 8:28:27 AM

Saturday, May 02, 2020 8:28:27 AM

Post# of 426050
ilt@ I would like to push your line of thinking a bit futher.
----------------------------------

John Thero has a number of times mentioned that Amarin will go for compensation of the lost provenue caused by generic Patent suet by Hikma and Reddy.
-----------------------------------

Just to put this in perspective 'Compensation in US caughts' is not something to be taken lightly.

https://www.nbcnews.com/news/us-news/monsanto-parent-company-bayer-faces-thousands-roundup-cancer-cases-after-n1007246

https://edition.cnn.com/2014/07/19/us/florida-tobacco-verdict/index.html
------------------------------------

Question is - what would the AMRN SP be today if there had been no Patent lawsuit from Hikma and Reddy. The difference of that' and the actual SP - when we reach the Appeal date - is what Amarin should/will claim in compensation (what Amarin has lost because of patent case):

So lets assume that SP when reaching appeal date is 10$ - i would say that AMRN in a free market - going forward after FDA CDV Approval december 2019 would be at least 35$ - with all the great news along the way - Canada - Q4 - EU and China on the way.

Now we have an easy way to calculate Amarins compensation claim:

Number of shares times lost SP price per share (360.000.000 x 25) = 9 billion dollars.

Plus the legal costs - and other expenses brought on by the lawsuit.

I hope Hikma and Reddy has put money aside - to compensate a Honest Company - they almost destroyed with their greedy and cynical lawsuit.

Jasbg

NB: I'm a lay person in Law. I think this i the logic way of calculating compensation - but will not be surprised if real Law people says different :)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News